Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Claro, Juan Carlos ^a   Candia, Roberto ^a   Rada, Gabriel ^a   Larrondo, Francisco ^b   Baraona, Fernando ^a   Letelier, Luz M ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD DEL DESARROLLO   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; PLACEBO;

CARDIOVASCULAR RISK; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFICACY; HEART ARREST; HEART DEATH; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIMARY PREVENTION; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SECONDARY PREVENTION; SUDDEN DEATH; SYNCOPE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 77950122040     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008093     Document Type: Review

References (34)

1. AVID 1997 The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. New England Journal of Medicine 1997;337:1576-83.
2. Bardy 2005 Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al.Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New England Journal of Medicine 2005;352:225-37.
3. Buxton 2000 Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, et al.Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. New England Journal of Medicine 2000;342(26):1937-45.
4. Buxton 2002 Buxton AE, Lee KL, Hafley GE, Wyse DG, Fisher JD, Lehmann MH, et al.Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial. Circulation 2002;106(19):2466-72.
5. Chugh 2004 Chugh SS, Jui J, Gunson K, Stecker EC, John BT, Thompson B, et al.Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. Journal of the American College of Cardiology 2004;44:1268-75.
6. Connolly 1997 Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997;350(9089):1417-24.
7. Connolly 2000 Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, et al.Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-302.
8. Consensus 1997 Consensus Statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States. Survivors of out-of-hospital cardiac arrest with apparently normal heart. Circulation 1997;95:265-72.
9. Coplen 1990 Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation 1990;82(4):1106-16.
10. DAVIT II 1990 The Danish Verapamil Infarction Trial II Investigators. Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II - DAVIT II). American Journal of Cardiology 1990;66(10):779-85.
11. Desai 2004 Desai AS, Fang JC, Maisel WH, Baughman KL. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA 2004;292(23):2874-9.
12. Ferreira 2007 Ferreira-Gonzalez I, Dos-Subira L, Guyatt GH. Adjunctive antiarrhythmic drug therapy in patients with implantable cardioverter defibrillators: a systematic review. European Heart Journal 2007;28(4):469-77.
13. Gehi 2006 Gehi AK, Mehta D, Gomes JA. Evaluation and Management of Patients after implantable cardioverter-defibrillator shock. JAMA 2006;296(23):2839-47.
14. Heidenreich 2002 Heidenreich PA, Keeffe B, McDonald KM, Hlatky MA. Overview of randomized trials of antiarrhythmic drugs and devices for the prevention of sudden cardiac death. American Heart Journal 2002; 144(3):422-30.
15. Higgins 2008 Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008.
16. Kannel 1982 Kannel WB, Thomas HE Jr. Sudden coronary death: The Framingham Study. Annals of the New York Academy of Sciences 1982;382:3-21.
17. Kannel 1998 Kannel WB, Wilson PW, D'Agostino RB, Cobb J. Sudden coronary death in women. American Heart Journal 1998;136:205-12.
18. Kuck 2000 Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-54.
19. Køber 2000 Køber L, Bloch-Thomsen PE, Møller M, Torp-Pedersen C, Carlsen J, Sandøe E, et al.Effect of dofetilide in patients with recent myocardial infarction and left ventricular dysfunction: a randomized trial. Lancet 2000;356:2052-8.
20. Lefebvre 2008 Lefebvre C, Manheimer E, Glanville J (editors). Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008.
21. Mark 2008 Mark DB, Anstrom KJ, Sun JL, Clapp-Channing NE, Tsiatis AA, Davidson-Ray L, et al.Quality of life with defibrillator therapy or amiodarone in heart failure. New England Journal of Medicine 2008;359(10):999-1008.
22. MMWR 2002 MMWR. State-specific mortality from sudden cardiac death - United States, 1999. Morbidity and Mortality Weekly Report 2002;51:123-6.
23. Myerburg 2004 Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In: Braunwald E editor(s). Heart disease: a textbook of cardiovascular medicine. 7th Edition. New York: WB Saunders Publishing Co, 2004:865.
24. Namerow 1999 Namerow PB, Firth BR, Heywood GM, Windle JR, Parides MK. Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: findings from the CABG Patch Trial. Pacing and Clinical Electrophysiology: PACE 1999;22(9):1305-13.
25. Pollak 1999 Pollak PT. Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations. American Journal of Cardiology 1999;84(9A):37R-45R.
26. Priori 2001 Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, et al.Task Force on Sudden Cardiac Death of the European Society of Cardiology. European Heart Journal 2001;22 (16):1374-450.
27. Siddoway 2003 Siddoway LA. Amiodarone: Guides for use and monitoring. American Family Physician 2003;68(11):2189-96.
28. Spaulding 1997 Spaulding CM, Joly, LM, Rosenberg A, Monchi M, Weber SN, Dhainaut JF, et al.Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. New England Journal of Medicine 1997;336:1629-33.
29. Strickberger 2003 Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, et al.Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia - AMIOVIRT. Journal of the American College of Cardiology 2003;41(10):1707-12.
30. Torp-Pedersen 1999 Torp-Pedersen C, Møller M, Bloch-Thomsen PE, Køber L, Sandøe E, Egstrup K, et al.Dofetilide in patients with congestive heart failure and left ventricular dysfunction. New England Journal of Medicine 1999;341:857-65.
31. Waldo 1996 Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, et al.Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996;348(9019):7-12.
32. Wilber 1990 Wilber DJ, Olshansky B, Moran JF, Scanlon PJ. Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function. Circulation 1990;82(2):350-8.
33. Yusuf 1985 Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta-blockade during and after myocardial infarction: an overview of the randomized trials. Progress in Cardiovascular Disease 1985;27:335-71.
34. Zheng 2001 Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001;104: 2158-63.